Mitral valve prolapse in systemic lupus erythematosus

F. Barzizza, A. Venco, A. M. Grandi, G. Finardi

Research output: Contribution to journalArticlepeer-review


Despite a low incidence of clinical manifestations, autopsy data suggest endocardial and myocardial disease in about 50% of patients with systemic lupus erythematosus. To investigate whether mitral valve prolapse can be considered a clinical manifestation of cardiac involvement in systemic lupus erythematosus, we carried out an echocardiographic study in 51 affected subjects and 102 normals matched for age and sex. Prevalence of mitral valve prolapse was 25% in patients with systemic lupus erythematosus and 9% in healthy controls with a statistically significant difference (p

Original languageEnglish
Pages (from-to)59-62
Number of pages4
JournalClinical and Experimental Rheumatology
Issue number1
Publication statusPublished - 1987

ASJC Scopus subject areas

  • Immunology
  • Rheumatology


Dive into the research topics of 'Mitral valve prolapse in systemic lupus erythematosus'. Together they form a unique fingerprint.

Cite this